AssureMDx

Categories

Description

A noninvasive urine test for the early detection and risk assessment of bladder cancer in patients with hematuria.

Summary

AssureMDx is a urine-based test designed to help physicians identify patients with hematuria who are at increased risk for bladder cancer, facilitating timely referral to urology for further clinical evaluation. The test evaluates genomic changes associated with bladder cancer, including DNA methylation status and somatic mutation status of specific genes, to stratify patients by risk and potentially avoid unnecessary invasive procedures for those at low risk.

Use Cases

• A primary care physician uses AssureMDx to assess the risk of bladder cancer in a patient presenting with hematuria.
• A clinic incorporates AssureMDx into their protocol to streamline the referral process to urology for patients at high risk of bladder cancer.